Clinical Trials Show Relapsing Multiple Sclerosis Patients Benefit from MAVENCLAD, A New Drug by MERCK
Merck Sdn Bhd has launched MAVENCLAD (cladribine), a short-course oral therapy now approved in Malaysia for the treatment of adult...
Merck Sdn Bhd has launched MAVENCLAD (cladribine), a short-course oral therapy now approved in Malaysia for the treatment of adult...
Since the beginning of the pandemic, individuals are now more aware and have taken more initiative to be more physically...
A team of University of Alberta researchers has discovered a way to use 3-D bioprinting technology to create custom-shaped cartilage...
Minister of Science, Technology and Innovation Khairy Jamaluddin announced that the intervals between the first and second doses of the...
The Selangor government announced today it will provide free mass Covid-19 screenings to all those residing in every constituency as...
Sunway Medical Centre Velocity (SMCV) is providing patients from government hospitals the opportunity to receive treatments from the hospital at...
Bringing hope and quality to cancer care in Asia, Integrated Oncology Centres (IOC) is one of the region’s first connected...